Skip to main content

Perrigo: Crushed It!

Not all specialty drug makers are suffering. Shares of Perrigo (PRGO) are soaring after the drug maker boosted its full-year profit forecast following estimate-beating third quarter results that crushed expectations. “Great quarter on multiple fronts,” wrote Wells Fargo analyst David Maris in a note published today. …The results are a dramatic turnaround from the previous […]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.